This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

PSL-001

PreScience Labs, LLC

Drug Names(s): 3–bromopyruvate, 3–BrPA

Description: PSL-001 targets the tumor glycolysis pathway. One of the key enzymes in tumor glycolysis, GAPDH, is the primary target of PSL-001. PSL-001 irreversibly binds to GAPDH resulting in a multi-prong assault on cancer cells, ultimately leading to their death.


PSL-001 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug